科前生物：第三季度净利润同比上升9.17%

Group 1 - The core viewpoint of the article is that 科前生物 (KQ Bio) reported a decline in operating revenue for Q3 2025, while net profit showed an increase year-on-year [1] Group 2 - The operating revenue for Q3 2025 was 251 million yuan, representing a year-on-year decrease of 5.44% [1] - The net profit attributable to shareholders of the listed company was 118 million yuan, which is a year-on-year increase of 9.17% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 84.62 million yuan, reflecting a year-on-year decrease of 7.06% [1]